CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | Stuglik Brian M Director | Grant or award | +8,333 | 97,380 | ||
| 2024-06-18 | Stuglik Brian M Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-06-18 | JOHNSON JOHN Director | Grant or award | +8,333 | 8,333 | ||
| 2024-06-18 | JOHNSON JOHN Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-06-17 | Gagnon Robert E. Director | Sale | −283 | $3.49 | $988 | 27,108 |
| 2024-06-17 | Paterson Dan President and CEO | Sale | −244 | $3.49 | $852 | 86,246 |
| 2024-06-17 | Stuglik Brian M Director | Sale | −593 | $3.49 | $2K | 89,047 |
| 2024-04-05 | Calkins Daniel Chief Financial Officer | Sale | −6 | $10.87 | $65 | 8,535 |
| 2024-03-25 | Calkins Daniel Chief Financial Officer | Sale | −25 | $12.02 | $301 | 8,541 |
| 2024-03-20 | Calkins Daniel Chief Financial Officer | Sale | −55 | $11.07 | $609 | 8,566 |
| 2024-03-19 | Gagnon Robert E. Director | Sale | −130 | $10.38 | $1K | 27,391 |
| 2024-03-19 | Paterson Dan President and CEO | Sale | −182 | $10.38 | $2K | 86,490 |
| 2024-03-19 | Stuglik Brian M Director | Sale | −273 | $10.38 | $3K | 89,640 |
| 2024-03-18 | Gagnon Robert E. Director | Sale | −283 | $10.71 | $3K | 27,521 |
| 2024-03-18 | Paterson Dan President and CEO | Sale | −244 | $10.71 | $3K | 86,672 |
| 2024-03-18 | Stuglik Brian M Director | Sale | −537 | $10.71 | $6K | 89,913 |
| 2024-03-11 | Bunn Paul A. Director | Returned to the company · Stock Option (right to buy) | −6,113 | 0 | ||
| 2024-03-11 | Bunn Paul A. Director | Grant or award · Stock Option (right to buy) | +6,113 | 6,113 | ||
| 2024-03-11 | Stuglik Brian M Director | Returned to the company · Stock Option (right to buy) | −4,166 | 0 | ||
| 2024-03-11 | Stuglik Brian M Director | Returned to the company · Stock Option (right to buy) | −7,699 | 0 |
Page 8 of 17 · 326 trades